Supplemental Table 3 from Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

التفاصيل البيبلوغرافية
العنوان: Supplemental Table 3 from Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature
المؤلفون: Paresh Vyas, Jamie D. Cavenagh, Michael Dennis, Shamyla Siddique, Richard J. Kelly, Srinivas P. Pillai, Mary Frances McMullin, Keith Wheatley, Louise Dudley, Sandeep Nagra, Manoj Raghavan, Angela Hamblin, Alison Kennedy, Natalia Garcia-Martin, Marlen Metzner, Corran Roberts, Emma Gbandi, Paul Ferguson, Lynn Swun Quek, Aimee E. Houlton, Charles F. Craddock
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Table S3. Variants detected by NGS targeted re-sequencing
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30cac8136a16ee1bad22e1c2d07a962dTest
https://doi.org/10.1158/1078-0432.22468974.v1Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....30cac8136a16ee1bad22e1c2d07a962d
قاعدة البيانات: OpenAIRE